Epigenetics Market worth $3.9 billion by 2027 - Exclusive Report by MarketsandMarkets™
CHICAGO, July 15, 2022 /PRNewswire/ -- According to the new market research report "Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Software, Service), Method (DNA Methylation), Technique (NGS, PCR & qPCR), Application (Oncology, Immunology), End User - Global Forecast to 2027", published by MarketsandMarkets™, the Epigenetics Market is valued at USD 1.7 billion in 2022 and is expected to reach USD 3.9 billion by 2027 at a CAGR of 18.1% during the forecast period.
Browse in-depth TOC on "Epigenetics Market"
270 – Tables
39 – Figures
248 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=896
The demand for epigenetic enzymes has elevated significantly over the years, particularly in drug discovery and development. In addition, advancements technologies targeted towards epigenetic analysis supplements this increased demand. Moreover, robust funding and investment in epigenetics market, especially in PCR and NGS segments is expected to propel market growth. The pace of R&D in innovative genetic technologies and epigenetics product development has increased over the years, attributed to the high investments in turn driving the market growth. However, variability within the reference epigenomes in heterogeneous sample groups makes it difficult to employ epigenetics solutions in toxicology studies. This is expected to restraint the market growth to a certain extent.
The kits & reagents segment dominated the epigenetics market in 2021
Based on product & service, the global market is segmented into kits & reagents, enzymes, instruments and accessories, software, and service. Antibodies is the highest revenue contributor of this segment, increasing adoption of antibodies in detection, identification, and alteration/modification of proteins followed by their role in monitoring cell regulation & expression, driving the segment growth. Broad applications of antibodies in epigenetics research across different techniques such as, immunofluorescence, western blotting, and ChIP has propelled various market players to expand their product offerings around traditional as well as recombinant antibodies
The DNA methylation segment has accounted for the highest share of epigenetics market in 2021
Based on method, the global epigenetic market is segmented into DNA methylation, histone modifications, and other methods. Various approaches are incorporated to perform DNA methylation, namely, enzyme-based digestion, bisulfite conversion, and methylated DNA enrichment. Among these, bisulfite conversion approach has gained significant traction and has become the gold-standard method to perform DNA methylation. This has encouraged local and international market participants to invest in this market space, further driving the market growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=896
The cardiovascular diseases segment is expected to register the highest growth during the forecast period
Based on applications, the epigenetics market is segmented into oncology, metabolic diseases, immunology, developmental biology, cardiovascular diseases, and other applications. Potential applications of epigenetics solutions in the characterization and identification of key biomarkers to design innovative therapeutic approaches and in assessment of at-risk patients has driven the segment growth. Additionally, increase in the number of epigenetics research activities aimed at gaining a deeper understanding of the CVDs is set to propel the segment growth.
Asia Pacific has registered fastest growth rate during the forecast period in the epigenetics market
The global epigenetic market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific market is anticipated to grow at the fastest pace from 2022 to 2027, which attributed to the expanding international presence of domestic players by adopting strategic agreements, partnerships, and collaborations. Japan has emerged as the key contributor to the Asia Pacific market revenue in 2021, private & government organizations promoting epigenetics research, local players focusing on introducing innovative epigenetics products, and robust collaborative research studies between the academic & research institutes and pharmaceutical companies collectively drive the regional growth.
The epigenetics market is moderately consolidated with prominent players operating in this market such as Thermo Fisher Scientific (US), Merck KGaA (Germany), Illumina, Inc. (US), PacBio (US), Abcam plc (UK), Active Motif, Inc. (US), Bio-Rad Laboratories (US), Promega Corporation (US), PerkinElmer (US), Qiagen (Germany), New England Biolabs (US), Zymo Research Corporation (US), Diagenode (Germany), and F. Hoffmann-La Roche Ltd (Switzerland).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=896
Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting
Browse Related Reports:
Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) – Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html
Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/epigenetics-technologies-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/epigenetics-technologies.asp
Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
SOURCE MarketsandMarkets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article